blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3658118

EP3658118 - METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  17.02.2023
Database last updated on 13.09.2024
FormerRequest for examination was made
Status updated on  01.05.2020
FormerThe international publication has been made
Status updated on  02.02.2019
Most recent event   Tooltip13.09.2024Change - applicantpublished on 16.10.2024 [2024/42]
Applicant(s)For all designated states
Novavax, Inc.
700 Quince Orchard Road
Gaithersburg, MD 20878 / US
[2024/42]
Former [2020/23]For all designated states
Novavax, Inc.
21 Firstfield Road
Gaithersburg, MD 20878 / US
Inventor(s)01 / SMITH, Gale
c/o NOVAVAX Inc.
21 Firstfield Road
Gaithersburg, Maryland 20878 / US
02 / LIU, Ye
c/o NOVAVAX Inc.
21 Firstfield Road
Gaithersburg, Maryland 20878 / US
03 / TIAN, Jing-Hui
c/o NOVAVAX Inc.
21 Firstfield Road
Gaithersburg, Maryland 20878 / US
04 / MASSARE, Michael
c/o NOVAVAX Inc.
21 Firstfield Road
Gaithersburg, Maryland 20878 / US
05 / BODDAPATI, Sarathi
c/o NOVAVAX Inc.
21 Firstfield Road
Gaithersburg, Maryland 20878 / US
06 / GLENN, Gregory
c/o NOVAVAX Inc.
21 Firstfield Road
Gaithersburg, Maryland 20878 / US
07 / FRIES, Louis
c/o NOVAVAX Inc.
21 Firstfield Road
Gaithersburg, Maryland 20878 / US
08 / CHO, Iksung
c/o NOVAVAX Inc.
21 Firstfield Road
Gaithersburg, Maryland 20878 / US
 [2020/23]
Representative(s)Danner, Stefan
Danner BioPharm IP
Ludwigstraße 8
80539 München / DE
[N/P]
Former [2020/23]Cooley (UK) LLP
Dashwood
69 Old Broad Street
London EC2M 1QS / GB
Application number, filing date18838914.224.07.2018
[2020/23]
WO2018US43431
Priority number, dateUS201762536235P24.07.2017         Original published format: US 201762536235 P
[2020/23]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019023196
Date:31.01.2019
Language:EN
[2019/05]
Type: A1 Application with search report 
No.:EP3658118
Date:03.06.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 31.01.2019 takes the place of the publication of the European patent application.
[2020/23]
Search report(s)International search report - published on:US31.01.2019
(Supplementary) European search report - dispatched on:EP02.03.2021
ClassificationIPC:A61K9/14, A61K9/51, A61K31/047, A61K38/16, A61K39/12, A61K39/145, A61P31/14
[2021/13]
CPC:
A61K9/5115 (EP); A61K9/5123 (US); A61K39/12 (EP);
A61K39/155 (US); A61P11/00 (US); A61P31/14 (EP,US);
C12N2760/16022 (US); C12N2760/16034 (US); C12N2760/18522 (EP,US);
C12N2760/18534 (EP,US) (-)
Former IPC [2020/23]A61K9/14, A61K9/51, A61K31/047, A61K38/16, A61K39/12, A61K39/145
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/23]
TitleGerman:VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON ATEMWEGSERKRANKUNGEN[2020/23]
English:METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE[2020/23]
French:MÉTHODES ET COMPOSITIONS POUR TRAITER LA MALADIE RESPIRATOIRE[2020/23]
Entry into regional phase22.01.2020National basic fee paid 
22.01.2020Search fee paid 
22.01.2020Designation fee(s) paid 
22.01.2020Examination fee paid 
Examination procedure22.01.2020Examination requested  [2020/23]
21.09.2021Amendment by applicant (claims and/or description)
21.02.2023Despatch of a communication from the examining division (Time limit: M04)
03.07.2023Reply to a communication from the examining division
Fees paidRenewal fee
27.07.2020Renewal fee patent year 03
27.07.2021Renewal fee patent year 04
27.07.2022Renewal fee patent year 05
27.07.2023Renewal fee patent year 06
29.07.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US2013011443  (FATTOM ALI I [US], et al);
 [XY]WO2017102737  (GLAXOSMITHKLINE BIOLOGICALS SA [BE]);
 [Y]US2017202948  (SMITH GALE [US], et al);
International search[A]US2009257980  (DAVIES DONNA ELIZABETH [GB], et al);
 [A]US2013064867  (FATTOM ALI I [US], et al);
 [A]US2015320854  (RADOSEVIC KATARINA [NL], et al);
 [X]US2017202948  (SMITH GALE [US], et al);
by applicantUS4911928
 EP0436620
 US5057540
 EP0363279
 US5629021
 US6231859
 US6352697
 US6387373
 US6524584
 US6846489
 US7776343
 US2011305727
 US8173141
 US2013011443
 WO2017102737
 US2017202948
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.